Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Whellan

Showing results (101-110 of 185) with videos related to

Pageof 19
Sort By:
American Heart Journal|June 19, 2018
Treatment of sleep-disordered breathing in heart failure impacts cardiac remodeling: Insights from the CAT-HF TrialMelissa A Daubert, David J Whellan, Holger Woehrle, et al.
American Heart Journal|September 29, 2009
Outcomes, health policy, and managed care: relationships between patient-reported outcome measures and clinical measures in outpatients with heart failureKathryn E Flynn, Li Lin, Stephen J Ellis, et al.
The American Journal of Cardiology|May 10, 2016
Comparison of Frequency of Frailty and Severely Impaired Physical Function in Patients ≥60 Years Hospitalized With Acute Decompensated Heart Failure Versus Chronic Stable Heart Failure With Reduced and Preserved Left Ventricular Ejection FractionGordon R Reeves, David J Whellan, Mahesh J Patel, et al.
JACC. Clinical Electrophysiology|May 30, 2017
Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?Wayne C Levy, Yanhong Li, Shelby D Reed, et al.
Journal of Cardiac Failure|December 6, 2013
Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTIONMona Fiuzat, Phillip J Schulte, Michael Felker, et al.
Journal of Cardiac Failure|September 21, 2020
Cognition, Physical Function, and Quality of Life in Older Patients With Acute Decompensated Heart FailureAmy M Pastva, Christina E Hugenschmidt, Dalane W Kitzman, et al.
American Heart Journal|January 24, 2007
Long-term costs and resource use in elderly participants with congestive heart failure in the Cardiovascular Health StudyLawrence Liao, Kevin J Anstrom, John S Gottdiener, et al.
Circulation. Cardiovascular Quality and Outcomes|December 8, 2011
Introduction of the Tools for Economic Analysis of Patient Management Interventions in Heart Failure Costing Tool: a user-friendly spreadsheet program to estimate costs of providing patient-centered interventionsShelby D Reed, Yanhong Li, Shital Kamble, et al.
The American Journal of Cardiology|March 17, 2004
Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failureKaren E Joynt, Wendy A Gattis, Vic Hasselblad, et al.
JACC. Heart Failure|August 13, 2018
Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN TrialWei Jiang, David J Whellan, Kirkwood F Adams, et al.
Pageof 19

Showing results (101-110 of 185) with videos related to

Sort By:
Pageof 19
American Heart Journal|June 19, 2018
Treatment of sleep-disordered breathing in heart failure impacts cardiac remodeling: Insights from the CAT-HF TrialMelissa A Daubert, David J Whellan, Holger Woehrle, et al.
American Heart Journal|September 29, 2009
Outcomes, health policy, and managed care: relationships between patient-reported outcome measures and clinical measures in outpatients with heart failureKathryn E Flynn, Li Lin, Stephen J Ellis, et al.
The American Journal of Cardiology|May 10, 2016
Comparison of Frequency of Frailty and Severely Impaired Physical Function in Patients ≥60 Years Hospitalized With Acute Decompensated Heart Failure Versus Chronic Stable Heart Failure With Reduced and Preserved Left Ventricular Ejection FractionGordon R Reeves, David J Whellan, Mahesh J Patel, et al.
JACC. Clinical Electrophysiology|May 30, 2017
Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?Wayne C Levy, Yanhong Li, Shelby D Reed, et al.
Journal of Cardiac Failure|December 6, 2013
Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTIONMona Fiuzat, Phillip J Schulte, Michael Felker, et al.
Journal of Cardiac Failure|September 21, 2020
Cognition, Physical Function, and Quality of Life in Older Patients With Acute Decompensated Heart FailureAmy M Pastva, Christina E Hugenschmidt, Dalane W Kitzman, et al.
American Heart Journal|January 24, 2007
Long-term costs and resource use in elderly participants with congestive heart failure in the Cardiovascular Health StudyLawrence Liao, Kevin J Anstrom, John S Gottdiener, et al.
Circulation. Cardiovascular Quality and Outcomes|December 8, 2011
Introduction of the Tools for Economic Analysis of Patient Management Interventions in Heart Failure Costing Tool: a user-friendly spreadsheet program to estimate costs of providing patient-centered interventionsShelby D Reed, Yanhong Li, Shital Kamble, et al.
The American Journal of Cardiology|March 17, 2004
Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failureKaren E Joynt, Wendy A Gattis, Vic Hasselblad, et al.
JACC. Heart Failure|August 13, 2018
Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN TrialWei Jiang, David J Whellan, Kirkwood F Adams, et al.
Pageof 19